Empowering investors with access to the best research, experts and opportunities.
19th April 2025
19th May 2025
16th May 2024
Live Investor Briefing
In this session Felix Gold Executive Director Joseph Webb discussed their plans to develop a potential multi million ounce high grade gold resource.
Speaker
DR Gerard Dyson Managing Director – Spectur Limited (ASX: SP3)
18th April 2024
In this session Far East Gold’s CEO and Director Shane Menere discussed the standout assays from our Woyla drilling campaigns that form the base of our upcoming maiden JORC resource publication.
9th April 2024
In this session Prescient CEO and Managing Director Steven Yatomi-Clarke discussed why the data from their PTX-100 Phase 1b trial is so promising.
25th March 2024
In this session Prescient CEO and Managing Director Steven Yatomi-Clarke provide a company update on strategy and upcoming milestones.
DR Gerard Dyson
Managing Director – Spectur Limited (ASX: SP3)
14th March 2024
Join Stuart Roberts, co-founder and senior analyst at Pitt Street Research, for an online briefing where he will outline the recent Pitt Street Research report on Prescient Therapeutics.
22nd February 2024
In this session Far East Gold’s CEO and Director Shane Menere discussed, why the Board (including Nickel Industries MD Justin Werner) is optimistic about the findings so far……
15th February 2024
In this session Wellnex Life MD Zack Bozinovski and Non-Executive Chairman Mario Tascone discussed what attracted Mario to Wellnex and where he sees the future of the business;
28th September 2022
Prescient Therapeutics (ASX: PTX) is a clinical-stage oncology company focused on developing next-generation personalised cancer therapies within the total global US$280 billion (2021) oncology industry.
This week we were joined by the CEOs of exciting ASX listed businesses: Prescient Therapeutics Limited (ASX: PTX) and Aerometrex (ASX: AMX).
15th September 2022
Spectur (ASX: SP3) MD Gerard Dyson discusses how the company’s wide technological moat leaves the company with no direct competition, its weighted sales pipeline which has grown 94% year-on-year as at June 2022, and how Spectur are ready to scale and move into its next growth phase.
14th September 2022
Praemium Limited (ASX: PPS) is an award-winning finance software company with $40.5 billion in total funds under administration
Webcentral Limited (ASX: WCG) is one of Australia’s largest full-service digital services partners for small and medium businesses
Wellnex Life (ASX: WNX) is an Australian brand innovation and distribution company servicing the $10.7 billion Australian health and wellness market
This week we were joined by the CEOs of exciting ASX listed businesses: Wellnex Life Limited (ASX: WNX), Webcentral Limited (ASX: WCG) and Praemium Limited (ASX: PPS).
26th August 2022
Propell (ASX: PHL) CEO Michael Davidson discusses how the company is successfully disrupting the banks with its innovative lending model, its exponential growth in its user base and revenues in the past year, and plans to take a significant portion of Australia’s $423 billion SME loan book.
17th August 2022
EBR Systems Inc (ASX: EBR) is the world’s only provider of wireless, endocardial (inside the heart) pacing systems in a US$2.5 billion addressable market.
Adherium Limited (ASX: ADR) is a global leader in connected respiratory medical devices, with more than 170,000 sold and 180 patents and designs globally.
This week we were joined by the CEOs of exciting ASX listed businesses: Adherium Limited (ASX: ADR) and EBR Systems Inc (ASX: EBR).
15th August 2022
TZ Limited (ASX: TZL) CEO Mario Vecchio provides a company update, and discusses how TZ’s market-leading software has uniquely positioned them as a category leader and helped them sign on world-class clients.
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.